Acacia Research (NASDAQ:ACTG) is a publicly traded patent licensing company based in New York City. The firm specializes in acquiring patented technologies through a network of wholly owned subsidiaries and seeking licensing agreements or settlements with companies that utilize those technologies. Since its founding in 1993, Acacia has built a business model centered on identifying innovative inventions and monetizing them through patent enforcement and strategic partnerships.
The company’s activities span a broad range of technology sectors, including life sciences, medical devices, software, telecommunications and consumer electronics. By leveraging its legal and technical expertise, Acacia seeks to maximize returns for its investors and patent owners by negotiating licensing arrangements or, when necessary, initiating litigation to enforce patent rights. Over the years, it has amassed a portfolio of patents and patent applications acquired from inventors, research institutions and corporations.
Acacia operates on a global scale, pursuing opportunities in key markets across North America, Europe and Asia. Its subsidiaries are structured to focus on specific technologies or industry verticals, allowing specialized teams to manage licensing and enforcement efforts. This approach has enabled the company to adapt to evolving markets and protect intellectual property in multiple jurisdictions.
Throughout its history, Acacia Research has maintained a management team with deep experience in intellectual property law, technology commercialization and corporate finance. The company’s leadership has overseen strategic acquisitions of patent portfolios and guided its subsidiaries through complex negotiations and legal proceedings, positioning Acacia as one of the prominent entities in the patent monetization industry.
